Cryoport sells CRYOPDP to DHL for $195M enterprise value, forms strategic partnership

Cryoport, Inc.

Divests CRYOPDP to DHL for total enterprise value of $195M; ~$138M cash plus repayment of ~$67M intercompany loans.
Strategic partnership formed with DHL to enhance global life sciences supply chain offerings.
Transaction expected to close in Q2 or Q3 2025, subject to regulatory approvals.
CRYOPDP handles over 600K shipments/year across 15 countries; DHL's pharma logistics revenue >EUR5B in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.